X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (670) 670
Publication (191) 191
Conference Proceeding (26) 26
Book Review (12) 12
Book Chapter (6) 6
Patent (5) 5
Book / eBook (3) 3
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (425) 425
humans (414) 414
female (344) 344
middle aged (329) 329
aged (319) 319
male (241) 241
risk factors (239) 239
oncology (223) 223
adult (216) 216
article (150) 150
cancer (146) 146
public, environmental & occupational health (134) 134
case-control studies (133) 133
hematology (126) 126
risk (123) 123
aged, 80 and over (118) 118
epidemiology (101) 101
cohort studies (95) 95
prospective studies (81) 81
abridged index medicus (80) 80
health aspects (80) 80
research (79) 79
young adult (78) 78
lymphoma (76) 76
lymphomas (70) 70
iowa - epidemiology (67) 67
mortality (67) 67
incidence (64) 64
lymphoma, non-hodgkin - epidemiology (62) 62
surveys and questionnaires (60) 60
prognosis (59) 59
polymorphism, single nucleotide (57) 57
genetic predisposition to disease (56) 56
hemic and lymphatic diseases (56) 56
united-states (56) 56
women (55) 55
non-hodgkin lymphoma (52) 52
proportional hazards models (51) 51
odds ratio (50) 50
adolescent (49) 49
association (49) 49
follow-up (49) 49
non-hodgkin's lymphomas (47) 47
genetic aspects (45) 45
lymphoma, non-hodgkin - genetics (44) 44
survival (44) 44
united states - epidemiology (44) 44
postmenopausal women (43) 43
follow-up studies (42) 42
analysis (41) 41
breast cancer (41) 41
population (41) 41
lymphoma, non-hodgkin - etiology (40) 40
immune system diseases (38) 38
disease (37) 37
postmenopause (37) 37
body mass index (36) 36
diet (35) 35
older women (35) 35
b-cell lymphoma (34) 34
leukemia (33) 33
medicine, general & internal (33) 33
non-hodgkin-lymphoma (33) 33
follicular lymphoma (32) 32
genotype (32) 32
neoplasms (32) 32
seer program (32) 32
smoking (31) 31
breast neoplasms - epidemiology (30) 30
diagnosis (30) 30
breast-cancer (29) 29
polymorphisms (29) 29
risk assessment (29) 29
survival rate (29) 29
genetic variation (28) 28
logistic models (28) 28
medical research (28) 28
rituximab (28) 28
expression (27) 27
age factors (26) 26
confidence intervals (26) 26
health risk assessment (26) 26
non-hodgkins-lymphoma (25) 25
registries (25) 25
treatment outcome (25) 25
disease-free survival (24) 24
multivariate analysis (24) 24
smoking - adverse effects (24) 24
cigarette-smoking (23) 23
classification (23) 23
age (22) 22
breast neoplasms - genetics (22) 22
care and treatment (22) 22
genome-wide association study (22) 22
prevalence (22) 22
internal medicine (21) 21
life sciences (21) 21
medicin och hälsovetenskap (21) 21
obesity (21) 21
polymorphism (21) 21
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Mayo Clinic Proceedings, ISSN 0025-6196, 06/2019
OBJECTIVETo assess cumulative radiation doses from computed tomography (CT), patient characteristics, and clinical indications for CT in a population-based... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2019, Volume 186, Issue 6, pp. 820 - 828
The diabetes mellitus (DM) drug metformin targets mechanistic/mammalian target of rapamycin and inhibits lymphoma growth in vitro . We investigated whether... 
mTOR | metformin | diabetes mellitus | follicular lymphoma | diffuse large B‐cell lymphoma | Lymphomas | Hypoglycemic agents | Diabetes | Epidemiology | TOR protein | Diabetes mellitus | Rapamycin | Lymphoma | Beta cells | Confidence intervals | Body mass index | Body mass | Lymphocytes B | Body size | Metformin | Index Medicus
Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2019, Volume 94, Issue 6, pp. 658 - 666
Indolent B‐cell lymphomas other than follicular lymphoma account for up to 10% of all B‐cell neoplasms. While they typically follow a slowly progressive... 
RELAPSE | SCORE | FREE SURVIVAL | RITUXIMAB | VALIDATION | RISK | CLASSIFICATION | HODGKIN-LYMPHOMA | MODEL | MARGINAL ZONE LYMPHOMA | HEMATOLOGY | Lymphocytes B | Early experience | Mucosal-associated lymphoid tissue | Mortality | Clinical trials | Lymphomas | Diagnosis | Lymphoma
Journal Article
American Journal of Hematology, ISSN 0361-8609, 12/2018, Volume 93, Issue 12, pp. 1543 - 1550
The impact of physical activity (PA) on lymphoma survival is not known. The association of PA and change in PA with overall (OS), lymphoma‐specific (LSS) and... 
BREAST-CANCER | ADULT SURVIVORS | COLON-CANCER | VITAMIN-D INSUFFICIENCY | NON-HODGKINS-LYMPHOMA | MOLECULAR EPIDEMIOLOGY | SMOKING | QUALITY-OF-LIFE | HEMATOLOGY | EXERCISE | PROGRESSION | Physical fitness | Lymphomas | Exercise | Physical activity | Clinical trials | Diagnosis | Health risk assessment | Lymphoma | Survival | Cancer
Journal Article
Nutrition and Cancer, ISSN 0163-5581, 10/2018, Volume 70, Issue 7, pp. 1088 - 1090
Dietary factors that may reduce the risk of relapse or prolong remission are an area of interest for patients with cancer. There is little data on the role of... 
RISK | NUTRITION & DIETETICS | EVENT-FREE SURVIVAL | ONCOLOGY | Risk reduction | Lymphoma | Fatty acids | Patients | Diet | Lymphocytes B | Medical prognosis | Biomarkers | Remission | Bioindicators | Lymphomas | Cancer | B-cell lymphoma
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 11/2016, Volume 66, Issue 6, pp. 443 - 459
Journal Article